e-learning – Long term macrolide use in respiratory conditions

31st July 2020 by NASGP

e-learning – Long term macrolide use in respiratory conditions

This is a new guideline from BTS, which outlines how to safely prescribe long term macrolide therapy in respiratory conditions. It was published in April 2020.

Most of the time, long term macrolide therapy will be initiated in secondary care. However we may well be the ones actually writing the prescription, so it is worth being aware of some of the safety concerns.

New points for me were:

  • The need for ECG and LFT before and during therapy.
  • The potential ototoxic effects.

What should be checked before a patient starts on long term macrolide therapy?

Read for free

Sign up to access everything.

Three-month free trial

Login

Already a member? Login to view this content.

Login

"I think the Spip and Cudos tool both have a very positive future and fulfil a real need."

Dr Amy Kerstein

See the full list of features within our NASGP membership plans

Membership